KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Leases (2019 - 2026)

Fulgent Genetics' Leases history spans 8 years, with the latest figure at $7.7 million for Q1 2026.

  • On a quarterly basis, Leases rose 1101.09% to $7.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.7 million, a 1101.09% increase, with the full-year FY2025 number at $5.0 million, down 8.04% from a year prior.
  • Leases hit $7.7 million in Q1 2026 for Fulgent Genetics, up from $5.0 million in the prior quarter.
  • Over the last five years, Leases for FLGT hit a ceiling of $18.0 million in Q2 2022 and a floor of $640000.0 in Q1 2025.
  • Historically, Leases has averaged $8.2 million across 5 years, with a median of $6.7 million in 2022.
  • Biggest five-year swings in Leases: plummeted 93.06% in 2025 and later surged 1101.09% in 2026.
  • Tracing FLGT's Leases over 5 years: stood at $14.8 million in 2022, then decreased by 26.69% to $10.8 million in 2023, then crashed by 50.22% to $5.4 million in 2024, then fell by 8.04% to $5.0 million in 2025, then soared by 54.95% to $7.7 million in 2026.
  • Business Quant data shows Leases for FLGT at $7.7 million in Q1 2026, $5.0 million in Q4 2025, and $5.0 million in Q3 2025.